"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease." Neurology
---- Lubberding AF, Veedfald S, Achter JS, Nissen SD, Soattin L, Sorrentino A, Vega ET, Linz B, Eggertsen CHE, Mulvey J, Torng S, Larsen SA, Nissen A, Petersen LG, Bilir SE, Bentzen BH, Rosenkilde MM, Hartmann B, Liller TNB, Qazi S, Mller CH, Tfelt-Hansen J, Sattler SM, Jespersen T, Holst JJ, Lundby A
While genetic variations in GLP-1 receptor expression or downstream signaling pathways may influence individual treatment response, routine genetic testing isn't currently recommended for predicting outcomes
You don't really need aas tbh, not with your trt numbers
doi: 10.3390/ijms26073388 26 AnchimowiczJZielonkaPJakielaS
Properly stored reconstituted peptides remain stable for 4 to 6 weeks